3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
6
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Recurrent Squamous Cell Lung Carcinoma
2
Melanoma
2
Hodgkin Disease
2
Thymoma
1
Small Cell Lung Carcinoma
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Inoperable Åsophageal Cancer
1
Gastric and Esophagogastric Junction Adenocarcinoma
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Brain Neoplasms
1
Advanced Solid Tumors
1
Adenocarcinoma
1
Interventions
Nivolumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Advanced Solid Tumors
×
Nivolumab
×
Clear all
NCT03461952
2024-02-22
NIMBLe
Canadian Cancer Trials Group
Phase 2
Terminated
4 enrolled
4 charts